Enhancing Biomarker-Driven Care and Disability Detection in Multiple Sclerosis: Clinical and Pharmacy Practice Strategies

EP. 1: Understanding the Multiple Sclerosis Disease Continuum and the Consequences of Untreated Progression
ByJacquelyn Bainbridge, PharmD, FCCP, FAES, MSCS,Kiranpal Singh Sangha, PharmD,Ryan Fuller, PharmD,Aimee M. Banks, PharmD, BCPS, MSCS,Millad Sobhanian, PharmD, BCPS Explore innovative strategies for identifying and managing multiple sclerosis through expert insights on biomarker-driven care and clinical practices.

EP. 2: Pharmacist Best Practices in Early Multiple Sclerosis Detection and Disability Identification
ByJacquelyn Bainbridge, PharmD, FCCP, FAES, MSCS,Kiranpal Singh Sangha, PharmD,Ryan Fuller, PharmD,Aimee M. Banks, PharmD, BCPS, MSCS,Millad Sobhanian, PharmD, BCPS Discover the significance of PIRA in multiple sclerosis (MS) and how pharmacists enhance early detection and patient care in MS management.